Translational Medicine (eBook, PDF)
The Future of Therapy?
Redaktion: Mittra, James; Milne, Christopher-Paul
100,95 €
100,95 €
inkl. MwSt.
Sofort per Download lieferbar
50 °P sammeln
100,95 €
Als Download kaufen
100,95 €
inkl. MwSt.
Sofort per Download lieferbar
50 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
100,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
50 °P sammeln
Translational Medicine (eBook, PDF)
The Future of Therapy?
Redaktion: Mittra, James; Milne, Christopher-Paul
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This book brings together a range of academic, industry and practitioner perspectives on translational medicine (TM). It enhances conceptual and practical understanding of the emergence and progress of the field and its potential impact on basic research, therapeutic development, and institutional infrastructure. In recognition of the various impli
- Geräte: PC
- mit Kopierschutz
- eBook Hilfe
- Größe: 3.17MB
Andere Kunden interessierten sich auch für
- Craig MallinckrodtEstimands, Estimators and Sensitivity Analysis in Clinical Trials (eBook, PDF)44,95 €
- Mark ChangAdaptive Design Theory and Implementation Using SAS and R (eBook, PDF)40,95 €
- Guosheng YinClinical Trial Design (eBook, PDF)118,99 €
- Mallikarjun B. HanjiMeta-Analysis in Psychiatry Research (eBook, PDF)86,95 €
- Michael J. CampbellHow to Design, Analyse and Report Cluster Randomised Trials in Medicine and Health Related Research (eBook, PDF)72,99 €
- Modeling Dose-Response Microarray Data in Early Drug Development Experiments Using R (eBook, PDF)40,95 €
- Edgar BrunnerRank and Pseudo-Rank Procedures for Independent Observations in Factorial Designs (eBook, PDF)97,95 €
-
-
-
This book brings together a range of academic, industry and practitioner perspectives on translational medicine (TM). It enhances conceptual and practical understanding of the emergence and progress of the field and its potential impact on basic research, therapeutic development, and institutional infrastructure. In recognition of the various impli
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 294
- Erscheinungstermin: 19. April 2016
- Englisch
- ISBN-13: 9789814364843
- Artikelnr.: 40068713
- Verlag: Taylor & Francis
- Seitenzahl: 294
- Erscheinungstermin: 19. April 2016
- Englisch
- ISBN-13: 9789814364843
- Artikelnr.: 40068713
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
James Mittra is a research fellow and lecturer at the ESRC Innogen Centre and Science, Technology and Innovation Studies subject group at the University of Edinburgh. His research and teaching focuses on interdisciplinary approaches to the complex and dynamic ways in which life sciences are affecting the nature and the process of technological and therapeutic innovation within the pharmaceutical and biotechnology sectors. Dr. Mittra has published widely on issues of the strategic management and governance of the life sciences, as well as on mapping new value systems and business models for novel therapies. Christopher-Paul Milne is director of research at the Tufts Center for the Study of Drug Development. His current research interests include academic-industry collaborations; disease, demographic, and market access factors in the emerging markets; incentive programs for pediatric studies, orphan products, and neglected diseases; and tracking the progress of new regulatory and research initiatives such as regulatory science, comparative effectiveness research, translational medicine, and personalized medicine. Dr. Milne is also research assistant professor at Tufts University Medical School, member of the editorial board of the Food & Drug Law Journal, and an honorary fellow at the University of Edinburgh.
Introduction: Introduction to Translational Medicine. Drivers and Barriers
to Translational Medicine: New Light Through an Old Window? The
"Translational Turn" in Biomedical Research - A Historical Perspective.
Translational Medicine: The Industry Perspective. Drivers and Barriers of
Translational Medicine: A Regulatory Perspective. Developing an Evaluation
Model for Translational Medicine Research Programs. State of the Art in
Science and Technology: Emerging Concepts in Biomarker Discovery: Cancer
Immunotherapy and Degenerative Diseases of the Eye as Model Systems.
Imaging Biomarkers for Innovative Drug Development: Translation from Bench
to Bedside and Back. Translational Bioinformatics: Bridging the Biological
and Clinical Divide. Institutional Dynamics of Translational Medicine:
Exploiting Translational Medicine Through Public-Private Partnerships: A
Case Study of Scotland's Translational Medicine Research Collaboration
(TMRC). The Role of the Product Development Partnership as a Translational
Mechanism for Delivering Health Solutions in Low-Resource Settings.
Conclusions: Is Translational Medicine the Future of Therapy?
to Translational Medicine: New Light Through an Old Window? The
"Translational Turn" in Biomedical Research - A Historical Perspective.
Translational Medicine: The Industry Perspective. Drivers and Barriers of
Translational Medicine: A Regulatory Perspective. Developing an Evaluation
Model for Translational Medicine Research Programs. State of the Art in
Science and Technology: Emerging Concepts in Biomarker Discovery: Cancer
Immunotherapy and Degenerative Diseases of the Eye as Model Systems.
Imaging Biomarkers for Innovative Drug Development: Translation from Bench
to Bedside and Back. Translational Bioinformatics: Bridging the Biological
and Clinical Divide. Institutional Dynamics of Translational Medicine:
Exploiting Translational Medicine Through Public-Private Partnerships: A
Case Study of Scotland's Translational Medicine Research Collaboration
(TMRC). The Role of the Product Development Partnership as a Translational
Mechanism for Delivering Health Solutions in Low-Resource Settings.
Conclusions: Is Translational Medicine the Future of Therapy?
Introduction: Introduction to Translational Medicine. Drivers and Barriers
to Translational Medicine: New Light Through an Old Window? The
"Translational Turn" in Biomedical Research - A Historical Perspective.
Translational Medicine: The Industry Perspective. Drivers and Barriers of
Translational Medicine: A Regulatory Perspective. Developing an Evaluation
Model for Translational Medicine Research Programs. State of the Art in
Science and Technology: Emerging Concepts in Biomarker Discovery: Cancer
Immunotherapy and Degenerative Diseases of the Eye as Model Systems.
Imaging Biomarkers for Innovative Drug Development: Translation from Bench
to Bedside and Back. Translational Bioinformatics: Bridging the Biological
and Clinical Divide. Institutional Dynamics of Translational Medicine:
Exploiting Translational Medicine Through Public-Private Partnerships: A
Case Study of Scotland's Translational Medicine Research Collaboration
(TMRC). The Role of the Product Development Partnership as a Translational
Mechanism for Delivering Health Solutions in Low-Resource Settings.
Conclusions: Is Translational Medicine the Future of Therapy?
to Translational Medicine: New Light Through an Old Window? The
"Translational Turn" in Biomedical Research - A Historical Perspective.
Translational Medicine: The Industry Perspective. Drivers and Barriers of
Translational Medicine: A Regulatory Perspective. Developing an Evaluation
Model for Translational Medicine Research Programs. State of the Art in
Science and Technology: Emerging Concepts in Biomarker Discovery: Cancer
Immunotherapy and Degenerative Diseases of the Eye as Model Systems.
Imaging Biomarkers for Innovative Drug Development: Translation from Bench
to Bedside and Back. Translational Bioinformatics: Bridging the Biological
and Clinical Divide. Institutional Dynamics of Translational Medicine:
Exploiting Translational Medicine Through Public-Private Partnerships: A
Case Study of Scotland's Translational Medicine Research Collaboration
(TMRC). The Role of the Product Development Partnership as a Translational
Mechanism for Delivering Health Solutions in Low-Resource Settings.
Conclusions: Is Translational Medicine the Future of Therapy?